Scarica l'app Stockscreener
47.89
0.03%
0.02
Tourmaline Bio Inc Azioni (TRML) Dati Finanziari
Conto economico
Trimestrale
*Tutti i numeri sono espressi in milioni
| Data di fine periodo | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
| Durata del periodo | 3 mesi | 3 mesi | 3 mesi | 3 mesi |
| Revenues |
-
|
- | - | - |
Operating Expenses
|
7.34%
26.23
|
24.44 | 21.97 | 17.52 |
| Operating Income/Loss |
7.34%
-26.23
|
-24.44 | -21.97 | -17.52 |
| Income/Loss From Continuing Operations Before Tax |
13.84%
-22.97
|
-20.18 | -17.49 | -13.31 |
| Income/Loss From Continuing Operations After Tax |
13.84%
-22.97
|
-20.18 | -17.49 | -13.31 |
|
Net Income/Loss
|
13.84%
-22.97
|
-20.18 | -17.49 | -13.31 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - |
| Basic Average Shares |
0.29%
25.69
|
25.77 | 25.72 | 24.08 |
| Diluted Average Shares |
0.29%
25.69
|
25.77 | 25.72 | 24.08 |
| Basic Earnings Per Share |
14.10%
-0.89
|
-0.78 | -0.68 | -0.55 |
| Diluted Earnings Per Share |
14.10%
-0.89
|
-0.78 | -0.68 | -0.55 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - |
1.09%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):